We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.86M
AUM Growth
-$188M
Cap. Flow
-$186M
Cap. Flow %
-1,882.29%
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611

Top Buys

Rank Stock Value
1
ACVA icon
ACV Auctions
ACVA
+$194K
2
RPD icon
Rapid7
RPD
+$183K
3
EFC
Ellington Financial
EFC
+$181K
4
SAN icon
Banco Santander
SAN
+$159K
5
OSCR icon
Oscar Health
OSCR
+$155K

Top Sells

Rank Stock Value
1
EXLS icon
EXL Service
EXLS
+$830K
2
DK icon
Delek US
DK
+$724K
3
AVGO icon
Broadcom
AVGO
+$669K
4
ITRI icon
Itron
ITRI
+$666K
5
EAT icon
Brinker International
EAT
+$649K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.83%
2 Technology 15.87%
3 Healthcare 10.98%
4 Industrials 10.86%
5 Real Estate 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARX
701
Accelerant Holdings
ARX
$2.96B
-23,839
Closed -$390K
CEPF
702
Cantor Equity Partners IV
CEPF
$596M
-13,892
Closed -$143K
KLAR
703
Klarna Group
KLAR
$7.09B
-8,268
Closed -$239K
ALH
704
Alliance Laundry Holdings
ALH
$4.87B
-11,408
Closed -$232K
NKLR
705
Terra Innovatum Global N.V.
NKLR
$568M
-25,852
Closed -$119K
GIW
706
GigCapital8
GIW
$368M
-16,607
Closed -$164K
CBC
707
Central Bancompany Inc
CBC
$7.62B
-16,076
Closed -$388K
MICC
708
The Magnum Ice Cream Company N.V.
MICC
$11.4B
-19,246
Closed -$305K

Similar funds

PharVision Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.

  • PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
  • PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
  • PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
  • PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
  • PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
  • PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
  • PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.